The PD-1 subpopulation was higher in Smad3-deficient tumor-specific CD8+ TILs, which led to enhanced cytokine production in TILs and draining lymph nodes, resulting in increased anti-tumor activity [84]. Here, CD8A is linked to neoplasm.